Asia Pacific Companion Diagnostics Market Size & Outlook

Name: Asia Pacific Companion Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The companion diagnostics market in Asia Pacific is expected to reach a projected revenue of US$ 3,539.2 million by 2030. A compound annual growth rate of 14.2% is expected of Asia Pacific companion diagnostics market from 2025 to 2030.

Clinical Diagnostics
- In Vitro Diagnostics
  - Companion Diagnostics Market Outlook

Asia Pacific companion diagnostics product and services outlook (Revenue, USD million, 2021-2033)
- Assays, Kits, and Reagents
- Instruments and Systems
- Software and Services
Asia Pacific companion diagnostics indication outlook (Revenue, USD million, 2021-2033)
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Other Indications
Asia Pacific companion diagnostics technology outlook (Revenue, USD million, 2021-2033)
- Polymerase Chain Reaction (PCR)
- Next-generation Sequencing (NGS)
- In-situ Hybridisation (ISH)
- "Immunohistochemistry (IHC) "
- Magnetic Resonance Imaging (MRI)
- Other Technology
Asia Pacific companion diagnostics type outlook (Revenue, USD million, 2021-2033)
- Tissue Samples
- Blood Samples
- Other Sample Types
Asia Pacific companion diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Academic and Research Centers
- Hospitals and Physician Laboratories
- CROs
- Reference Labaoratories
- Pharmaceutical and Biotechnology Companies
- Other End Use

Asia Pacific Companion Diagnostics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!